Literature DB >> 24141712

G protein-coupled receptor 43 moderates gut inflammation through cytokine regulation from mononuclear cells.

Ryuta Masui1, Makoto Sasaki, Yasushi Funaki, Naotaka Ogasawara, Mari Mizuno, Akihito Iida, Shinya Izawa, Yoshihiro Kondo, Yoshitsugi Ito, Yasuhiro Tamura, Kenichiro Yanamoto, Hisatsugu Noda, Atsushi Tanabe, Noriko Okaniwa, Yoshiharu Yamaguchi, Takashi Iwamoto, Kunio Kasugai.   

Abstract

BACKGROUND: Short-chain fatty acids (SCFAs), which are produced by the fermentation of dietary fiber by intestinal microbiota, may positively influence immune responses and protect against gut inflammation. SCFAs bind to G protein-coupled receptor 43 (GPR43). Here, we show that SCFA-GPR43 interactions profoundly affect the gut inflammatory response.
METHODS: Colitis was induced by adding dextran sulfate sodium to the drinking water of GPR43 knockout (-/-) and wild-type mice.
RESULTS: Dextran sulfate sodium-treated GPR43 mice exhibited weight loss, increased disease activity index (a combined measure of weight loss, rectal bleeding, and stool consistency), decreased hematocrit, and colon shortening, resulting in significantly worse colonic inflammation than in wild-type mice. Tumor necrosis factor alpha and interleukin 17 protein levels in the colonic mucosa of GPR43 mice were significantly higher than in wild-type mice. Treatment of wild-type mice with 150 mM acetate in their drinking water markedly improved these disease indices, with an increase in colon length and decrease in the disease activity index; however, it had no effect on GPR43 mice. Mononuclear cell production of tumor necrosis factor alpha after lipopolysaccharide stimulation was suppressed by acetate. This effect was inhibited by anti-GPR43 antibody.
CONCLUSIONS: SCFA-GPR43 interactions modulate colitis by regulating inflammatory cytokine production in mononuclear cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24141712     DOI: 10.1097/01.MIB.0000435444.14860.ea

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  60 in total

Review 1.  Microbiota metabolite regulation of host immune homeostasis: a mechanistic missing link.

Authors:  S Steinmeyer; K Lee; A Jayaraman; R C Alaniz
Journal:  Curr Allergy Asthma Rep       Date:  2015-05       Impact factor: 4.806

Review 2.  Role of Short Chain Fatty Acid Receptors in Intestinal Physiology and Pathophysiology.

Authors:  Medha Priyadarshini; Kumar U Kotlo; Pradeep K Dudeja; Brian T Layden
Journal:  Compr Physiol       Date:  2018-06-18       Impact factor: 9.090

Review 3.  Gut Microbiota and IL-17A: Physiological and Pathological Responses.

Authors:  Banafsheh Douzandeh-Mobarrez; Ashraf Kariminik
Journal:  Probiotics Antimicrob Proteins       Date:  2019-03       Impact factor: 4.609

4.  Loss of FFAR2 promotes colon cancer by epigenetic dysregulation of inflammation suppressors.

Authors:  Pan Pan; Kiyoko Oshima; Yi-Wen Huang; Kimberle A Agle; William R Drobyski; Xiao Chen; Jianying Zhang; Martha M Yearsley; Jianhua Yu; Li-Shu Wang
Journal:  Int J Cancer       Date:  2018-03-30       Impact factor: 7.396

5.  Expression of Free Fatty Acid Receptor 2 by Dendritic Cells Prevents Their Expression of Interleukin 27 and Is Required for Maintenance of Mucosal Barrier and Immune Response Against Colorectal Tumors in Mice.

Authors:  Sydney Lavoie; Eunyoung Chun; Sena Bae; Caitlin A Brennan; Carey Ann Gallini Comeau; Jessica K Lang; Monia Michaud; Hamid R Hoveyda; Graeme L Fraser; Miles H Fuller; Brian T Layden; Jonathan N Glickman; Wendy S Garrett
Journal:  Gastroenterology       Date:  2020-01-07       Impact factor: 22.682

Review 6.  Targeting gut microbiota as a possible therapy for mastitis.

Authors:  Xiaoyu Hu; Shumin Li; Yunhe Fu; Naisheng Zhang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-05-11       Impact factor: 3.267

7.  Loss of free fatty acid receptor 2 enhances colonic adenoma development and reduces the chemopreventive effects of black raspberries in ApcMin/+ mice.

Authors:  Pan Pan; Chad W Skaer; Hsin-Tzu Wang; Kiyoko Oshima; Yi-Wen Huang; Jianhua Yu; Jianying Zhang; Martha M Yearsley; Kimberle A Agle; William R Drobyski; Xiao Chen; Li-Shu Wang
Journal:  Carcinogenesis       Date:  2016-11-19       Impact factor: 4.944

Review 8.  Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases.

Authors:  Mingming Sun; Wei Wu; Zhanju Liu; Yingzi Cong
Journal:  J Gastroenterol       Date:  2016-07-23       Impact factor: 7.527

9.  A Pleiotropic Missense Variant in SLC39A8 Is Associated With Crohn's Disease and Human Gut Microbiome Composition.

Authors:  Dalin Li; Jean-Paul Achkar; Talin Haritunians; Jonathan P Jacobs; Ken Y Hui; Mauro D'Amato; Stephan Brand; Graham Radford-Smith; Jonas Halfvarson; Jan-Hendrik Niess; Subra Kugathasan; Carsten Büning; L Philip Schumm; Lambertus Klei; Ashwin Ananthakrishnan; Guy Aumais; Leonard Baidoo; Marla Dubinsky; Claudio Fiocchi; Jürgen Glas; Raquel Milgrom; Deborah D Proctor; Miguel Regueiro; Lisa A Simms; Joanne M Stempak; Stephan R Targan; Leif Törkvist; Yashoda Sharma; Bernie Devlin; James Borneman; Hakon Hakonarson; Ramnik J Xavier; Mark Daly; Steven R Brant; John D Rioux; Mark S Silverberg; Judy H Cho; Jonathan Braun; Dermot P B McGovern; Richard H Duerr
Journal:  Gastroenterology       Date:  2016-08-01       Impact factor: 22.682

Review 10.  SCFA Receptors in Pancreatic β Cells: Novel Diabetes Targets?

Authors:  Medha Priyadarshini; Barton Wicksteed; Gary E Schiltz; Annette Gilchrist; Brian T Layden
Journal:  Trends Endocrinol Metab       Date:  2016-04-15       Impact factor: 12.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.